# OnCo record paul-chapman (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/paul-chapman/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "paul-chapman" ;
  schema:name "Paul B. Chapman"@en ;
  schema:description "New York melanoma doctor who was lead author of BRIM-3, the trial that showed vemurafenib lengthens survival in BRAF-mutant melanoma and launched targeted therapy for the disease."@en ;
  schema:url <https://onco.cc/people/paul-chapman/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "melanoma", "targeted-therapy", "trialist" ;
  schema:jobTitle "Melanoma medical oncologist, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/braf-v600-melanoma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-chapman-vemurafenib-nejm-2011/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .